Skip to main content

Posts

Advocates Urge FDA to Revoke Approval of Painkiller Zohydro By Join Together Staff | February 26, 2014 | More than 40 addiction treatment, health care and consumer groups are urging the Food and Drug Administration (FDA) to reverse its decision to approve the prescription painkiller Zohydro ER (extended release), CNN reports. The drug is a pure form of the painkiller hydrocodone. The FDA approved Zohydro ER in October for patients with pain that requires daily, around-the-clock, long-term treatment that cannot be treated with other drugs. Drugs such as Vicodin contain a combination of hydrocodone and other painkillers such as acetaminophen. Zohydro ER is set to become available in March, the article notes. In December 2012, a panel of experts assembled by the FDA voted against recommending approval of Zohydro ER. The panel cited concerns over the potential for addiction. Zohydro is designed to be released over time, and can be crushed and snorted by people seeking a strong, quick...
DEA Joins Investigation Into Source of Deadly Heroin That Killed 22 In Western PA By Join Together Staff | January 29, 2014 The Drug Enforcement Administration has joined an investigation into the source of a batch of heroin that killed 22 people in western Pennsylvania, The Wall Street Journal reports. The heroin involved in some of the deaths contained the synthetic opiate fentanyl, often used during surgery. “We do have a good idea where it’s coming from,” Pennsylvania Attorney General Kathleen Kane said of the drug mix. “We’re trying to find the source and get them off the street before there are any more deaths.” Dr. Karl Williams, medical examiner for Allegheny County, said 15 overdose deaths in the county appeared to be linked to heroin and fentanyl. In an average week, there are five overdose deaths in the county. More nonfatal overdoses were also reported. Officials found bags of heroin mixed with fentanyl at the scene of overdose deaths stamped with the names “Therafl...
Drug use among U.S. workers declined 74% over past 25 years According to new analysis Drug use among U.S. workers declined dramatically over the past 25 years, although the rate of positive test results for certain drugs, including amphetamine and opiates, continues to climb, according to an analysis of workplace drug test results released by Quest Diagnostics, a provider of diagnostic information services. The release of the special 25th anniversary Drug Testing Index (DTI) coincides with the anniversary of the passage of the Drug-Free Workplace Act in 1988. The Act requires federal contractors and all federal grantees to agree to provide drug-free workplaces as a precondition of receiving a contract or grant from a federal agency. Although the Act did not require mandatory drug testing, federal agencies subsequently promulgated drug testing regulations affecting "safety-sensitive" employees and other federal employees. Many private employers also created policies consiste...
Surge in Synthetic Marijuana Emergency Room Visits Reported in Denver By Join Together Staff | January 23, 2014 Emergency rooms in Denver, Colorado reported a surge in visits related to synthetic marijuana in the late summer and early fall, according to the Los Angeles Times. Experts say similar patterns may emerge in other parts of the country. Between August 24 and September 19, area emergency rooms saw 263 patients, mostly young men, with symptoms related to synthetic marijuana. Most patients were treated in the emergency room, but seven were admitted to intensive care units. In a letter in this week’s New England Journal of Medicine, Dr. Andrew A. Monte of the University of Colorado School of Medicine writes synthetic marijuana appears to be growing more potent. “Although the effects of exposures to first-generation synthetic cannabinoids are largely benign, newer products have been associated with seizures, ischemic stroke and cardiac toxicity, possibly due to potency,” he wro...
Colorado Addiction Treatment Centers Brace for More Teens Referred for Marijuana Use By Join Together Staff | January 7, 2014 | Addiction treatment centers in Colorado are bracing for an increase in teens referred for marijuana use, ABC News reports. The state began legal sales of recreational marijuana for adults last week. While only people 21 and older are allowed to purchase marijuana, some experts are concerned the law will allow the drug to more easily fall into the hands of teens. Dr. Christian Thurstone, who heads the teen rehabilitation center Adolescent STEP: Substance Abuse Treatment Education & Prevention Program, said 95 percent of patient referrals to the program are for marijuana use. In preparation for the new law, Dr. Thurstone has doubled his staff. He told ABC News that marijuana can be harmful for some teens, particularly those suffering from mental illness. He said that after Colorado legalized medical marijuana in 2009, teens began to use much higher pot...
Alcohol-Related Car Crashes More Likely on New Year’s Eve Than Christmas Fatal car crashes are more likely to be caused by alcohol on New Year’s Eve, compared with Christmas, according to the National Safety Council. Bloomberg reports between 2007 and 2011, over the New Year’s holiday period—6 p.m. December 31 through 11:59 p.m. January 1—there were an average of 108 traffic deaths a day, with about 42 percent linked to alcohol. In contrast, there were 93 alcohol-related deaths between 6 p.m. December 24 and 11:59 p.m. December 25, with 35 percent linked to alcohol. This year, the group estimates that during Christmas, there will be 105 traffic deaths and 11,200 injuries requiring a medical professional, and 156 traffic deaths and 16,700 injuries during New Year’s. “The difference between the two holidays is that everybody on New Year’s Eve is going out to parties and at their parties, they’re having the alcohol,” Capt. Nancy Rasmussen, Chief of Public Affairs for the Florida Highw...
NO EASY ANSWER TO OPIOID ADDICTION EPIDEMIC By Join Together Staff | November 13, 2013 There are no easy answers to solving the opioid addiction epidemic, according to experts at the American Association for the Treatment of Opioid Dependence annual meeting this week. Thomas McLellan, CEO of the Treatment Research Institute, told NBC Philadelphia a multi-faceted approach is needed. “You don’t have any alternatives [to opioids]. The only alternative is a non-steroidal anti-inflammatory; well it’s got liver toxicity and it’s not all that potent. There’s nothing between that and a very powerful opioid,” said Dr. McLellan, who served as the Deputy Director of the White House Office of National Drug Control Policy. “This is one of those problems that society has to manage. You can’t do away with it. Not with 70 million older Americans who vote and are aging and need them. You can’t ban them.” Doctors don’t have proper training to understand opioid addiction, Dr. McLellan noted. “They ...